Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?

Gary S. Hoffman; Kathryn A. Wikenheiser; Edward B. Silberstein

Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?

Gary S. Hoffman, MD
Gary S. Hoffman
MD
Kathryn A. Wikenheiser, PhD
Kathryn A. Wikenheiser
Department of Radiology and Medicine, the University of Cincinnati Hospital
PhD
and Edward B. Silberstein, MD
Edward B. Silberstein
Department of Radiology and Medicine, the University of Cincinnati Hospital
MD

Cleveland Clinic Journal of Medicine
January 1996,
63
(1)
43-47;

ABSTRACT

SUMMARY It is recommended that routine bone scans not be adopted for follow-up of patients with stage I—II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.

INDEX TERMS

PDF

Previous Next

In this issue

Print
Download PDF
Article Alerts

Alerts for this Article

User Name *

Password *

Sign In to Email Alerts with your Email Address
Email *
Email Article

Email This Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following
Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?
Message Subject
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Citation Tools
Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?

Gary S. Hoffman

Gary S. Hoffman

Kathryn A. Wikenheiser

Kathryn A. Wikenheiser

and Edward B. Silberstein

Edward B. Silberstein

Cleveland Clinic Journal of Medicine

January 1996,

63

(1)

43-47;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Share
Share This Article
Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?

Gary S. Hoffman

Gary S. Hoffman

Kathryn A. Wikenheiser

Kathryn A. Wikenheiser

and Edward B. Silberstein

Edward B. Silberstein

Cleveland Clinic Journal of Medicine

January 1996,

63

(1)

43-47;

Share This Article:
Post